Initial post marketing experience with lacosamide in adult patients with epilepsy

Epilepsy Research

Volumn 98, Issue 2-3, 2012, Pages 260-263

  Harden, Cynthia L ^a   Cohn, Aaron ^b   Lowe, Merredith ^b   Serrano, Enrique ^b  

^a DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Adverse effects; Correlation; Dose; Epilepsy; Lacosamide; Responder rate

Indexed keywords

BENZODIAZEPINE; ETIRACETAM; HARKOSERIDE; LAMOTRIGINE; OXCARBAZEPINE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ADD ON THERAPY; ADULT; AGED; ANXIETY DISORDER; ARTICLE; ATONIC SEIZURE; COMBINATION CHEMOTHERAPY; COMPLEX PARTIAL SEIZURE; COORDINATION DISORDER; DIZZINESS; DRUG DOSE REDUCTION; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG INTERMITTENT THERAPY; DRUG RESPONSE; DRUG WITHDRAWAL; EPILEPSY; FEMALE; FRONTAL LOBE EPILEPSY; GRAND MAL EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MOOD DISORDER; POSTMARKETING SURVEILLANCE; PRESCRIPTION; PRIORITY JOURNAL; TEMPORAL LOBE EPILEPSY;

ACETAMIDES; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; PRODUCT SURVEILLANCE, POSTMARKETING; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84856448512     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2011.09.010     Document Type: Article

References (9)

1. Barnes K.L. Excitable cells: the ionic basis of membrane potentials. Comprehensive Clinical Neurophysiology 2000, 43-49. WB Saunders Company, Philadelphia. K.H. Levin, H.O. Luders (Eds.).
2. Beyreuther B.K., Freitag J., Heers C., et al. Lacosamide: a review of preclinical properties. CNS Drug Rev. 2007, 13:21-42.
3. Catterall W.A. From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 2000, 26:13-25.
4. Chung S., Sperling M.R., Biton V., et al. Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial. Epilepsia 2010, 51(6):958-967. On behalf of the SP754 Study Group.
5. Food and Drug Administration (FDA), 2008. FDA Labelling Information. FDA web site (online).
6. Harris J.A., Murphy J.A. Lacosamide and epilepsy. CNS Neurosci. Ther. 2010, October.
7. Shorvon S. Handbook of Epilepsy Treatment 2010, Wiley-Blackwell, Oxford. 3rd edition.
8. Stöhr T., Kupferberg H.J., Stables H.J., et al. Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy. Epilepsy Res. 2007, 74:147-154.
9. Walker M.C., Surges R., Fisher A. Mechanism of antiepileptic drug action. The Treatment of Epilepsy 2009, 91-108. Wiley-Blackwell, Oxford. 3rd edition. S. Shorvon, E. Perucca, J. Engel (Eds.).